start portlet menu bar end portlet menu bar

Characterization of recombinant verotoxin 2e during the production process

Strona główna Wiedza Characterization of recombinant verotoxin 2e during the production process

Characterization of recombinant verotoxin 2e during the production process

In this study, we present the characterization of the production process for the rVt2e. 

Pobierz ten artykuł

1,04 MB

O tym artykule

Opublikowano w

IPVS Congress China, 2018

Data

13.07.2018

Autorzy

Mallorquí, J.; Ferrer-Soler, L.; Panosa, C.; Bau, M.; Moreno, A.; Ruiz, M; Sitja, M.

Streszczenie

The purification step used in the rVt2e production process is essential in order to obtain a final rVt2e protein with a purity higher than 90% and with low endotoxin levels.

Powiązane produkty

VEPURED®

Powiązane publikacje

Safety of VEPURED® vaccine in two day old piglets Prevention of edema disease in pigs by vaccination with VEPURED® vaccine Efficacy of VEPURED® against edema disease in pigs under field conditions

Udostępnij na

start portlet menu bar

Characterization of recombinant verotoxin 2e during the production process

Display portlet menu
end portlet menu bar

Patrz także

Publikacje

Intradermal application of vaccines in pigs (Poster)

04-10-2018
Streszczenia choroby

Edema disease

03-11-2017
Aktualności

HIPRA takes a step forward in Taiwan with the launch of UNISTRAIN® PRRS vaccine

11-10-2018